161 related articles for article (PubMed ID: 25509109)
21. Tuning IL-2 signaling by ADP-ribosylation of CD25.
Teege S; Hann A; Miksiewicz M; MacMillan C; Rissiek B; Buck F; Menzel S; Nissen M; Bannas P; Haag F; Boyer O; Seman M; Adriouch S; Koch-Nolte F
Sci Rep; 2015 Mar; 5():8959. PubMed ID: 25753532
[TBL] [Abstract][Full Text] [Related]
22. CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells.
Ding Y; Yu A; Tsokos GC; Malek TR
J Immunol; 2019 Jul; 203(1):93-104. PubMed ID: 31085588
[TBL] [Abstract][Full Text] [Related]
23. The molecular mechanism of curcumol on inducing cell growth arrest and apoptosis in Jurkat cells, a model of CD4⁺ T cells.
Wang H; Wang Y; Jiang X; Wang Z; Zhong B; Fang Y
Int Immunopharmacol; 2014 Aug; 21(2):375-82. PubMed ID: 24877754
[TBL] [Abstract][Full Text] [Related]
24. Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex.
Rodriguez G; Ross JA; Nagy ZS; Kirken RA
J Biol Chem; 2013 Mar; 288(10):7137-46. PubMed ID: 23341462
[TBL] [Abstract][Full Text] [Related]
25. Genome profiling revealed the activation of IL2RG/JAK3/STAT5 in peripheral T‑cell lymphoma expressing the ITK‑SYK fusion gene.
Zhang LL; Pan HX; Wang YX; Guo T; Liu L
Int J Oncol; 2019 Nov; 55(5):1077-1089. PubMed ID: 31545408
[TBL] [Abstract][Full Text] [Related]
26. IL-2 enhances cervical cancer cells proliferation and JAK3/STAT5 phosphorylation at low doses, while at high doses IL-2 has opposite effects.
Valle-Mendiola A; Weiss-Steider B; Rocha-Zavaleta L; Soto-Cruz I
Cancer Invest; 2014 May; 32(4):115-25. PubMed ID: 24548303
[TBL] [Abstract][Full Text] [Related]
27. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
[TBL] [Abstract][Full Text] [Related]
28. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer.
Rocha-Zavaleta L; Huitron C; Cacéres-Cortés JR; Alvarado-Moreno JA; Valle-Mendiola A; Soto-Cruz I; Weiss-Steider B; Rangel-Corona R
Cell Signal; 2004 Nov; 16(11):1239-47. PubMed ID: 15337523
[TBL] [Abstract][Full Text] [Related]
30. STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferation.
Lockyer HM; Tran E; Nelson BH
J Immunol; 2007 Oct; 179(8):5301-8. PubMed ID: 17911616
[TBL] [Abstract][Full Text] [Related]
31. Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain.
Malka Y; Hornakova T; Royer Y; Knoops L; Renauld JC; Constantinescu SN; Henis YI
J Biol Chem; 2008 Nov; 283(48):33569-77. PubMed ID: 18829468
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin I2-IP signalling regulates human Th17 and Treg cell differentiation.
Liu W; Li H; Zhang X; Wen D; Yu F; Yang S; Jia X; Cong B; Ma C
Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):335-44. PubMed ID: 24035274
[TBL] [Abstract][Full Text] [Related]
33. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
[TBL] [Abstract][Full Text] [Related]
34. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.
Faller E; Kakal J; Kumar R; Macpherson P
Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839
[TBL] [Abstract][Full Text] [Related]
35. IL-6 activates STAT5 in T cells.
Tormo AJ; Letellier MC; Sharma M; Elson G; Crabé S; Gauchat JF
Cytokine; 2012 Nov; 60(2):575-82. PubMed ID: 22854263
[TBL] [Abstract][Full Text] [Related]
36. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154.
Säemann MD; Zeyda M; Diakos C; Szekeres A; Böhmig GA; Kelemen P; Parolini O; Stockinger H; Prieschl EE; Stulnig TM; Baumruker T; Zlabinger GJ
Transplantation; 2003 Jun; 75(11):1864-72. PubMed ID: 12811247
[TBL] [Abstract][Full Text] [Related]
37. Isoproterenol-induced beta-2 adrenergic receptor activation negatively regulates interleukin-2 signaling.
Ruiz-Medina BE; Cadena-Medina DA; Esparza E; Arrieta AJ; Kirken RA
Biochem J; 2018 Sep; 475(18):2907-2923. PubMed ID: 30120106
[TBL] [Abstract][Full Text] [Related]
38. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.
Burchill MA; Yang J; Vogtenhuber C; Blazar BR; Farrar MA
J Immunol; 2007 Jan; 178(1):280-90. PubMed ID: 17182565
[TBL] [Abstract][Full Text] [Related]
39. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation.
Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H
J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069
[TBL] [Abstract][Full Text] [Related]
40. Cutting Edge: Differential Fine-Tuning of IL-2- and IL-15-Dependent Functions by Targeting Their Common IL-2/15Rβ/γc Receptor.
Meghnem D; Morisseau S; Frutoso M; Trillet K; Maillasson M; Barbieux I; Khaddage S; Leray I; Hildinger M; Quéméner A; Jacques Y; Mortier E
J Immunol; 2017 Jun; 198(12):4563-4568. PubMed ID: 28507024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
